| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 110.41M | 117.87M | 131.96M | 137.21M | 159.76M | 151.41M |
| Gross Profit | 82.95M | 91.46M | 102.86M | 102.52M | 125.61M | 113.91M |
| EBITDA | 1.76M | 5.55M | 498.00K | 3.02M | 10.61M | 9.66M |
| Net Income | -1.66M | 2.49M | -2.24M | -4.49M | 9.84M | 6.26M |
Balance Sheet | ||||||
| Total Assets | 33.92M | 36.06M | 41.21M | 49.13M | 59.63M | 65.33M |
| Cash, Cash Equivalents and Short-Term Investments | 7.69M | 11.40M | 7.73M | 13.78M | 24.18M | 22.21M |
| Total Debt | 8.10M | 6.69M | 5.71M | 6.21M | 1.83M | 2.83M |
| Total Liabilities | 26.97M | 27.44M | 30.72M | 34.95M | 35.21M | 39.36M |
| Stockholders Equity | 6.95M | 8.61M | 10.48M | 14.18M | 24.41M | 25.97M |
Cash Flow | ||||||
| Free Cash Flow | -3.97M | 1.96M | -3.12M | -3.66M | 10.12M | 5.08M |
| Operating Cash Flow | -2.89M | 2.26M | -2.37M | -2.60M | 10.77M | 6.03M |
| Investing Cash Flow | -1.06M | -285.00K | -747.00K | -1.06M | -650.00K | -947.00K |
| Financing Cash Flow | -1.22M | 1.96M | -1.90M | -4.33M | -9.29M | -9.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $809.87M | 32.66 | 1.62% | 3.26% | -1.34% | -73.59% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $199.51M | 14.07 | 15.38% | ― | -5.47% | 13.42% | |
60 Neutral | $464.10M | 4.37 | 14.55% | 2.63% | -12.10% | ― | |
50 Neutral | $18.56M | ― | -19.54% | ― | -9.17% | -4.64% | |
50 Neutral | $13.84M | 2.21 | 16.79% | ― | 7.75% | -21.61% | |
46 Neutral | $175.02M | -4.90 | -18.73% | ― | -13.14% | 57.98% |
Mannatech Inc., a Texas-based company, specializes in developing, marketing, and selling nutritional supplements, skin care, anti-aging, and weight-management products through network marketing distribution channels across various global regions. In its latest earnings report for the quarter ending September 30, 2025, Mannatech Inc. reported a net income of $1.9 million, a significant improvement from a net loss of $328,000 in the same quarter of the previous year. However, the company faced a decline in net sales, which fell to $29.2 million from $31.7 million year-over-year. The company’s gross profit also saw a decrease, reflecting the challenges in maintaining sales momentum. Despite the drop in sales, Mannatech managed to reduce its operating expenses, which contributed to the positive net income for the quarter. The company also reported a comprehensive income of $1.06 million, factoring in foreign currency translations. Looking ahead, Mannatech’s management remains focused on strategic initiatives to enhance operational efficiency and expand its market presence, aiming to navigate the competitive landscape and drive future growth.
On September 9, 2025, Mannatech, Incorporated entered into Loan Extension Agreements with three board members and stockholders, extending the repayment of $3.6 million in loans to March 31, 2027. This extension allows Mannatech additional time to use the funds for general working capital needs, with the option to prepay without penalty.
The most recent analyst rating on (MTEX) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Mannatech stock, see the MTEX Stock Forecast page.
Mannatech Inc. faces significant risks to its profitability and market competitiveness due to potential changes in trade policies, including tariffs. The imposition of new tariffs or increases in existing ones between key trading partners like the United States, Mexico, and China could escalate costs and disrupt supply chains. Despite efforts to mitigate these impacts, such as shifting production locations, the company may struggle with operational complexities and competitive pressures. This could lead to increased prices, potential loss of customers, and adverse effects on revenue and market position.